Interesting facts
Interesting Facts about N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide is an intriguing compound recognized for its unique structure and potential applications in various fields. Here are some fascinating insights:
- Biological Significance: This compound belongs to the class of sulfonamide derivatives, which are known for their antibacterial properties. Sulfonamides, first introduced in the 1930s, revolutionized medicine by providing a new way to combat bacterial infections.
- Thiadiazole Ring: The presence of a thiadiazole ring in its structure is noteworthy. Compounds containing this heterocyclic structure often exhibit diverse biological activities, including antimicrobial and anticancer effects.
- Research Applications: Its unique chemical composition has made it a subject of interest in pharmaceutical research. Scientists are exploring its potential in drug development, particularly for treating resistant bacterial strains or even as a scaffold for new medicinal compounds.
- Mechanism of Action: The action mechanism of thiadiazole derivatives generally involves the inhibition of bacterial folic acid synthesis, making them effective against a wide range of pathogens.
In summary, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide is not just a chemical compound; it embodies a narrative of scientific exploration and innovation. As scientists continue to unravel its potential, it may lead to breakthroughs in healthcare and drug development.
Synonyms
acetazolamide
59-66-5
Diamox
Acetamox
Nephramide
Glaupax
N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
Acetazolamid
Defiltran
Phonurit
Donmox
Edemox
Didoc
Diuriwas
Cidamex
Diacarb
Diluran
Dehydratin
Natrionex
Nephramid
Diakarb
Diuramid
Diutazol
Duiramid
Eumicton
Fonurit
Vetamox
Glupax
SK-acetazolamide
5-Acetamido-1,3,4-thiadiazole-2-sulfonamide
Acetazolamida
Acetazolamidum
Acetazoleamide
Acetozalamide
Diureticum-holzinger
Acetamidothiadiazolesulfonamide
Glaumox
Diamox Sequels
4-Diamox
Atenezo
Carbonic Anhydrase Inhibitor No. 6063
2-Acetylamino-1,3,4-thiadiazole-5-sulfonamide
Acetamide, N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-
2-Acetamido-5-sulfonamido-1,3,4-thiadiazole
Acetazolamidum [INN-Latin]
N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide
Acetazolamida [INN-Spanish]
CCRIS 5811
NSC 145177
HSDB 3002
1,3,4-Thiadiazole-2-sulfonamide, 5-acetamido-
Carbonic anhydrase inhibitor 6063
EINECS 200-440-5
UNII-O3FX965V0I
5-Acetamide-1,3,4-thiadiazole-2-sulfonamide
N-(5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl)acetamide
NSC-145177
O3FX965V0I
DTXSID7022544
CHEBI:27690
AI3-52458
Acetazolamide (Standard)
CHEMBL20
MFCD00003105
Diamox (TN)
Acetamide, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-
MLS000028435
DTXCID002544
Acetamide, N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)-
5-acetylamino-1,3,4-thiadiazole-2-sulfonamide
Acetazolamide [USP:INN:BAN:JAN]
L 579486
NSC145177
CAS-59-66-5
NCGC00015074-10
Acetazolamine
Atenezol
SMR000058394
Acetazolamidum (INN-Latin)
Acetazolamida (INN-Spanish)
ACETAZOLAMIDE (MART.)
ACETAZOLAMIDE [MART.]
ACETAZOLAMIDE (USP-RS)
ACETAZOLAMIDE [USP-RS]
N-(5-[Aminosulfonyl]-1,3,4-thiadiazol-2-yl)acetamide
N-[5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide
ACETAZOLAMIDE (EP IMPURITY)
ACETAZOLAMIDE [EP IMPURITY]
Acetazolamide (USP:INN:BAN:JAN)
ACETAZOLAMIDE (EP MONOGRAPH)
ACETAZOLAMIDE [EP MONOGRAPH]
ACETAZOLAMIDE (USP MONOGRAPH)
ACETAZOLAMIDE [USP MONOGRAPH]
Acetazolamide (AAZ)
SR-01000000065
N-(5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl)acetamide
Prestwick_4
1azm
1yda
1ydb
1ydd
1zsb
2xtk
3czv
3ucj
Acetazolamide, 5
Acerazolamide, AAZ
Acetazolamide, AAZ
Acetazolamide, AZA
Acetazolamide, AZM
ACETAZIDE
ATENAZOL
Spectrum_000018
1jd0
2h4n
2uy4
3dc3
3hs4
3ml5
4g0c
Opera_ID_288
AZA2
Prestwick0_000003
Prestwick1_000003
Prestwick2_000003
Prestwick3_000003
Spectrum2_000082
Spectrum3_000284
Spectrum4_000139
Spectrum5_000738
Lopac-A-6011
ACETAZOLAMIDE [MI]
A 6011
ACETAZOLAMIDE [INN]
ACETAZOLAMIDE [JAN]
ACETAZOLAMIDE [HSDB]
Lopac0_000039
SCHEMBL23219
ACETAZOLAMIDE [VANDF]
BSPBio_000005
BSPBio_001788
KBioGR_000558
KBioSS_000358
MLS001148438
Acetazolamide Extended-Release
BIDD:GT0643
DivK1c_000017
SPECTRUM1500102
N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-acetamide
SPBio_000004
SPBio_001926
ACETAZOLAMIDE [WHO-DD]
ACETAZOLAMIDE [WHO-IP]
BPBio1_000007
GTPL6792
Acetazolamide, >=99%, powder
SCHEMBL11049053
BDBM10880
BZKPWHYZMXOIDC-UHFFFAOYSA-
HMS500A19
HY-B0782R
KBio1_000017
KBio2_000358
KBio2_002926
KBio2_005494
KBio3_001288
Acetazolamide (JP18/USP/INN)
S01EC01
Acetazolamide, analytical standard
NINDS_000017
HMS1568A07
HMS1920A05
HMS2091G05
HMS2095A07
HMS2232G23
HMS3259I13
HMS3260G19
HMS3370P01
HMS3712A07
HMS3744A21
Pharmakon1600-01500102
WLN: T5NN DSJ CSZW EMV1
ACETAZOLAMIDE [ORANGE BOOK]
ALBB-023617
BCP29616
HY-B0782
Tox21_110078
Tox21_201559
Tox21_302773
Tox21_500039
CCG-38900
NSC755854
s4506
ACETAZOLAMIDUM [WHO-IP LATIN]
AKOS000715163
Tox21_110078_1
CS-3568
DB00819
FA16948
LP00039
NC00491
NSC-755854
SDCCGSBI-0050028.P005
IDI1_000017
NCGC00015074-01
NCGC00015074-02
NCGC00015074-03
NCGC00015074-04
NCGC00015074-05
NCGC00015074-06
NCGC00015074-07
NCGC00015074-08
NCGC00015074-09
NCGC00015074-11
NCGC00015074-12
NCGC00015074-14
NCGC00015074-15
NCGC00015074-17
NCGC00015074-22
NCGC00023455-03
NCGC00023455-04
NCGC00023455-05
NCGC00023455-06
NCGC00023455-07
NCGC00256374-01
NCGC00259108-01
NCGC00260724-01
AC-12779
AS-13169
SBI-0050028.P004
2-Acetamido-5-sulfonamido-1,4-thiadiazole
5-Acetamide-1,4-thiadiazole-2-sulfonamide
DB-053437
5-Acetamido-1,3,4-thiadiazol-2-sulfonamide
A2598
AB00051906
CS-0694998
EU-0100039
NS00008947
1,4-Thiadiazole-2-sulfonamide, 5-acetamido-
CARBONIC ANHYDRASE INHIBITOR NO 6063
C06805
D00218
D88526
EN300-119493
AB00051906_15
A832415
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanamide
Q413690
SR-01000000065-2
SR-01000000065-4
SR-01000000065-6
1,3,4-THIADIAZOLE-2-SULFONAMIDE, 5-ACETAMIDO
2-ACETAMIDO-1,3,4-THIADIAZOLE-5-SULFONAMIDE
BRD-K43457670-001-22-9
BRD-K43457670-001-26-0
BRD-K43457670-001-27-8
Z277559108
(1z)-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanimidic acid
Acetazolamide, European Pharmacopoeia (EP) Reference Standard
Acetazolamide, United States Pharmacopeia (USP) Reference Standard
Acetazolamide for system suitability, European Pharmacopoeia (EP) Reference Standard
Acetazolamide, Pharmaceutical Secondary Standard; Certified Reference Material
124442-28-0
200-440-5
5-Acetamido-1,3,4-thiadiazole-2-sulfonamide;N-(5-[Aminosulfonyl]-1,3,4-thiadiazol-2-yl)acetamide;N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
InChI=1/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)
N-[5-Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide;5-Acetamido-1,3,4-thiadiazole-2-sulfonamide;Acetamox
Solubility of N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide (C4H6N4O3S2)
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide, with the molecular formula C4H6N4O3S2, exhibits a unique solubility profile that makes it interesting for various applications.
Key insights into its solubility include:
In conclusion, understanding the solubility behavior of N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide is crucial for its applications in pharmaceuticals and agricultural chemistry, making it a compound of significant interest in various fields.